The HepQuant management team is committed to fulfilling an unmet medical need: The development and successful proliferation of minimally invasive tests of the liver to improve diagnosis and aid clinical management.
Greg Everson, MD | CEO & Chief Medical Officer
Randy Dietrich | President
Sean Bundy | COO, Director of Regulatory & Quality Affairs
Steve Helmke | Chief Scientific Officer
Brad Everson | Chief Business Development Officer
Sarah Downing | Senior Manager, Quality Affairs
Lisa Goggin | Managing Director of Business Operations